全文获取类型
收费全文 | 102523篇 |
免费 | 4100篇 |
国内免费 | 230篇 |
专业分类
耳鼻咽喉 | 1491篇 |
儿科学 | 3088篇 |
妇产科学 | 2673篇 |
基础医学 | 13815篇 |
口腔科学 | 3027篇 |
临床医学 | 6152篇 |
内科学 | 23670篇 |
皮肤病学 | 2844篇 |
神经病学 | 7922篇 |
特种医学 | 2228篇 |
外国民族医学 | 2篇 |
外科学 | 13038篇 |
综合类 | 478篇 |
一般理论 | 26篇 |
预防医学 | 11347篇 |
眼科学 | 2322篇 |
药学 | 7577篇 |
中国医学 | 330篇 |
肿瘤学 | 4823篇 |
出版年
2023年 | 569篇 |
2022年 | 375篇 |
2021年 | 1730篇 |
2020年 | 894篇 |
2019年 | 1984篇 |
2018年 | 3411篇 |
2017年 | 2051篇 |
2016年 | 1981篇 |
2015年 | 2254篇 |
2014年 | 2478篇 |
2013年 | 3972篇 |
2012年 | 6769篇 |
2011年 | 6849篇 |
2010年 | 3512篇 |
2009年 | 2553篇 |
2008年 | 5681篇 |
2007年 | 5947篇 |
2006年 | 5739篇 |
2005年 | 5781篇 |
2004年 | 5310篇 |
2003年 | 4911篇 |
2002年 | 4676篇 |
2001年 | 3168篇 |
2000年 | 3354篇 |
1999年 | 2679篇 |
1998年 | 495篇 |
1996年 | 349篇 |
1992年 | 1268篇 |
1991年 | 1170篇 |
1990年 | 1091篇 |
1989年 | 979篇 |
1988年 | 891篇 |
1987年 | 895篇 |
1986年 | 837篇 |
1985年 | 795篇 |
1984年 | 589篇 |
1983年 | 467篇 |
1979年 | 598篇 |
1978年 | 345篇 |
1976年 | 323篇 |
1975年 | 349篇 |
1974年 | 533篇 |
1973年 | 497篇 |
1972年 | 434篇 |
1971年 | 394篇 |
1970年 | 467篇 |
1969年 | 427篇 |
1968年 | 407篇 |
1967年 | 370篇 |
1966年 | 317篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Katarzyna Kozar Rafal Kamiński Tomasz Switaj Tomasz O?dak Eugeniusz Machaj Piotr J Wysocki Andrzej Mackiewicz Witold Lasek Marek Jakóbisiak Jakub Go?ab 《Clinical cancer research》2003,9(8):3124-3133
PURPOSE: Recent findings indicating that many genes related to cancer development are silenced by an aberrant DNA methylation suggest that inhibitors of this process may be effective cancer therapeutics. In this study we investigated the efficacy of low-dose 5-aza-2'-deoxycitydine (DAC), a methylation inhibitor, with interleukin (IL) 12, one of the most potent cytokines with antitumor activity. Experimental Design: Mice inoculated with L1210 leukemia cells or with B16F10 melanoma cells were treated with 7 daily injections of low-dose DAC (0.2 mg/kg) and/or 7 daily doses of IL-12 (100 ng/dose). Scid/scid mice as well as monoclonal antibodies against CD4, CD8, and NK1.1 were used to investigate the mechanisms of the antitumor effects of the combination treatment. The activity of murine lymphocytes was measured with enzyme-linked immunospot and (51)Cr release assays. RESULTS: Treatment with DAC or IL-12 given alone produced moderate antitumor effects. In both tumor models combined treatment resulted in potentiated antitumor effects and produced 70% long-term survivors among mice inoculated with L1210 cells. The antitumor efficacy of combined treatment was abrogated in scid/scid mice, and after depletion of CD4(+) and CD8(+) T cells. Mice inoculated with B16F10 melanoma cells had significantly delayed tumor growth after combined treatment with DAC and IL-12. Strong antitumor effect correlated with a significant activation of lymph node-derived CD8(+) and CD4(+) cells. Transient neutropenia was observed in mice under treatment of DAC alone, but remarkably this effect was not potentiated by IL-12. CONCLUSIONS: This study provides the first evidence that antitumor effects of DAC can be strongly potentiated by IL-12 and could be beneficial in an effective low-dose-based antitumor therapy. 相似文献
992.
V Alberola C Camps M Provencio D Isla R Rosell C Vadell I Bover A Ruiz-Casado P Azagra U Jiménez J L González-Larriba P Diz F Cardenal A Artal A Carrato S Morales J J Sanchez R de las Pe?as E Felip G López-Vivanco 《Journal of clinical oncology》2003,21(17):3207-3213
PURPOSE: To compare the survival benefit obtained with cisplatin plus gemcitabine, a cisplatin-based triplet, and nonplatinum sequential doublets in advanced non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: Stage IIIB to IV NSCLC patients were randomly assigned to receive cisplatin 100 mg/m2 day 1 plus gemcitabine 1,250 mg/m2 days 1 and 8, every 3 weeks for six cycles (CG); cisplatin 100 mg/m2 day 1 plus gemcitabine 1,000 mg/m2 and vinorelbine 25 mg/m2 days 1 and 8, every 3 weeks for six cycles (CGV); or gemcitabine 1,000 mg/m2 plus vinorelbine 30 mg/m2 days 1 and 8, every 3 weeks for three cycles, followed by vinorelbine 30 mg/m2 days 1 and 8 plus ifosfamide 3 g/m2 day 1, every 3 weeks for three cycles (GV-VI). RESULTS: Five hundred fifty-seven patients were assigned to treatment (182 CG, 188 CGV, 187 GV-VI). Response rates were significantly inferior for the nonplatinum sequential doublet (CG, 42%; CGV, 41%; GV-VI, 27%; CG v GV-VI, P =.003). No differences in median survival or time to progression were observed. Toxicity was higher for the triplet: grade 3 to 4 neutropenia (GC, 32%; CGV, 57%; GV-VI, 27%; P <.05); neutropenic fever (CG, 4%; CGV, 19%; GV-VI, 5%; P <.0001); grade 3 to 4 thrombocytopenia (CG, 19%; CGV, 23%; GV-VI, 3%; P =.0001); and grade 3 to 4 emesis (GC, 22%; GCV, 32%; GV-VI, 6%; P <.0001). CONCLUSION: On the basis of these results, CG remains a standard regimen for first-line treatment of advanced NSCLC. 相似文献
993.
994.
Andrés Redondo Sánchez Javier de Castro Carpeño Manuel González Barón 《Clinical & translational oncology》2003,5(5):239-248
Esophageal cancer has a dismal prognosis and the surgical treatment only cures a small percentage of patients. The survival achieved by traditional surgical procedures is being improved with extended resections, but at the cost of greater morbidity. Concurrent radiochemotherapy can obtain results similar to those of surgery. Nowadays, locally advanced esophageal cancer should have a multimodal approach, because neoadjuvant chemotherapy, with or without radiotherapy, has demonstrated to improve the survival of chemosensitive patients. Recently, the role of hyperfractionated radiotherapy and new drugs such as paclitaxel, docetaxel and irinotecan in neoadjuvant treatment is being evaluated. 相似文献
995.
Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. 总被引:2,自引:0,他引:2
Marcin Makowski Tomasz Grzela Justyna Niderla Maciej ?Azarczyk Pawe? Mróz Maciej Kopeé Magdalena Legat Katarzyna Strusińska Katarzyna Koziak Dominika Nowis Piotr Mrówka Maria Wasik Marek Jakóbisiak Jakub Go?ab 《Clinical cancer research》2003,9(14):5417-5422
PURPOSE: The aim of the present study was to potentiate the antitumor effectiveness of photodynamic therapy (PDT). A cDNA microarray analysis was used to evaluate the gene expression pattern after Photofrin-mediated PDT to find more effective combination treatment with PDT and inhibitor(s) of the identified gene product(s) overexpressed in tumor cells. EXPERIMENTAL DESIGN: Atlas Mouse Stress Array was used to compare the expression profile of control and PDT-treated C-26 cells. The microarray results have been confirmed using Western blotting. Cytostatic/cytotoxic in vitro assay as well as in vivo tumor models were used to investigate the antitumor effectiveness of PDT in combination with cyclooxygenase (COX) 2 inhibitors. RESULTS: PDT induced the expression of 5 of 140 stress-related genes. One of these genes encodes for COX-2, an enzyme important in the tumor progression. Inhibition of COX-2 in vitro with NS-398, rofecoxib, or nimesulide, or before PDT with nimesulide did not influence the therapeutic efficacy of the treatment. Administration of a selective COX-2 inhibitor after PDT produced potentiated antitumor effects leading to complete responses in the majority of treated animals. CONCLUSIONS: COX-2 inhibitors do not sensitize tumor cells to PDT-mediated killing. However, these drugs can be used to potentiate the antitumor effectiveness of this treatment regimen when administered after tumor illumination. 相似文献
996.
997.
Sheila A Prindiville Tim Byers Fred R Hirsch Wilbur A Franklin York E Miller Kieu O Vu Holly J Wolf Anna E Barón Kenneth R Shroyer Chan Zeng Tim C Kennedy Paul A Bunn 《Cancer epidemiology, biomarkers & prevention》2003,12(10):987-993
Individuals with cytological atypia in sputum may be at increased risk for lung cancer. We conducted a longitudinal analysis of the association between lung cancer incidence and cytological atypia in sputum samples collected prospectively from an ongoing cohort of adults at high risk for lung cancer. Cohort members had a smoking history of > or = 30 pack-years and chronic obstructive pulmonary disease documented by pulmonary airflow testing. Sputum samples collected at baseline and periodically thereafter were examined by standard cytological methods. From the cohort of 2,006 people, there were 83 incident lung cancers over 4,469 person-years of observation. At baseline, the association between personal and behavioral characteristics, and sputum cytological atypia was assessed by multiple logistic regression. The association between sputum cytological atypia and incident lung cancer was then assessed by hazard ratios using proportional hazards regression analysis, adjusting for potential confounding factors. Cytological atypia graded as moderate or worse was associated with continuing cigarette smoking (adjusted odds ratio, 2.5; 95% confidence interval, 1.5-4.1), and with lower levels of intake of fruits and vegetables (P for trend = 0.04). Atypia was not associated with several other factors, including the degree of airflow obstruction, the use of vitamin supplements, nonsteroidal anti-inflammatory drugs, or metered-dose steroid inhalers. Incident lung cancer was increased among those with moderate or worse cytological atypia (adjusted hazards ratio, 2.8; 95% confidence interval, 1.4-5.5). This association was not confounded by other risk factors. We conclude that in this high-risk cohort, cytological atypia is associated with continuing smoking and low intake of fruits and vegetables, but that independent of these and other factors, the risk of incident lung cancer is increased among those with moderate or worse grades of cytological atypia in their sputum. 相似文献
998.
999.
Alvarez B Doménech N Alonso F Sánchez C Gómez del Moral M Ezquerra A Domínguez J 《Xenotransplantation》2000,7(4):258-266
Abstract: We describe in this report the production and characterization of monoclonal antibodies (mAb) to the swine homologues of CD11a and CD18 antigens, and their use for phenotypic and functional analysis of porcine leukocytes. Monoclonal antibodies BL1H8 and BL2F1 precipitated two bands of approximately 170 and 95 kDa, whereas mAb BA3H2 brought down three bands of 170, 155 and 95 kDa, from alveolar macrophage lysates. Clearance of macrophage lysates with mAbs BL1H8 and BL2F1 resulted in complete removal of the 170-kDa band. The cell distribution of the molecules recognized by these mAbs was similar to that of human LFA-1. It was found on all leukocytes, although its expression varied among the different leukocyte subpopulations, with monocytes, granulocytes and a subset of CD8+ cells expressing the highest levels. Cross-blocking studies showed that these antibodies recognize different epitopes on porcine LFA-1. Both anti-LFA-1 mAbs strongly inhibited the mitogenic response of PBMC to ConA, whereas the anti-CD18 mAb had no effect. These anti-LFA-1 mAbs also inhibited the mixed lymphocyte reaction (MLR) and the NK cell-mediated lysis of K-562 cells. 相似文献
1000.
Kisielnicka E Zdrojewski Z Wróblewska M Kortas B Rutkowski B 《Transplantation proceedings》2000,32(6):1358-1362